News | November 25, 2023
Laurus Labs acquires 87.59% stake in Laurus Bio Private
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Evinova will operate as a separate health-tech business within AstraZeneca
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
The company has raised US$4.5 million in funding for its AI operating system
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
The company expects that this development could improve the strength of its application to the FDA for new drug approval
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Subscribe To Our Newsletter & Stay Updated
